+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • PDF Icon

    Report

  • 146 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5729528
Description Jump to:
This report describes the global market size of Oncology Drugs from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Oncology Drugs as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment

  • Targeted Therapy
  • Chemotherapy
  • Hormonal Therapy
  • Biologic Therapy

Companies Covered

  • Roche
  • Merck & Co. Inc.
  • Johnson & Johnson
  • Bristol Myers Squibb
  • Pfizer
  • Novartis
  • AbbVie
  • Eli Lilly
  • Amgen
  • AstraZeneca
  • Takeda
  • GlaxoSmithKline
  • Sanofi
  • Merck KGaA
  • Ipsen
  • Bayer
  • Regeneron Pharmaceuticals
  • Gilead Sciences
  • Hengrui Pharma
  • Luye Pharma
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Oncology Drugs Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Oncology Drugs Market in North America (2019-2029)
8.1 Oncology Drugs Market Size
8.2 Oncology Drugs Market by End Use
8.3 Competition by Players/Suppliers
8.4 Oncology Drugs Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Oncology Drugs Market in South America (2019-2029)
9.1 Oncology Drugs Market Size
9.2 Oncology Drugs Market by End Use
9.3 Competition by Players/Suppliers
9.4 Oncology Drugs Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Oncology Drugs Market in Asia & Pacific (2019-2029)
10.1 Oncology Drugs Market Size
10.2 Oncology Drugs Market by End Use
10.3 Competition by Players/Suppliers
10.4 Oncology Drugs Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Oncology Drugs Market in Europe (2019-2029)
11.1 Oncology Drugs Market Size
11.2 Oncology Drugs Market by End Use
11.3 Competition by Players/Suppliers
11.4 Oncology Drugs Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Oncology Drugs Market in MEA (2019-2029)
12.1 Oncology Drugs Market Size
12.2 Oncology Drugs Market by End Use
12.3 Competition by Players/Suppliers
12.4 Oncology Drugs Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Oncology Drugs Market (2019-2024)
13.1 Oncology Drugs Market Size
13.2 Oncology Drugs Market by End Use
13.3 Competition by Players/Suppliers
13.4 Oncology Drugs Market Size by Type
Chapter 14 Global Oncology Drugs Market Forecast (2024-2029)
14.1 Oncology Drugs Market Size Forecast
14.2 Oncology Drugs Application Forecast
14.3 Competition by Players/Suppliers
14.4 Oncology Drugs Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Roche
15.1.1 Company Profile
15.1.2 Main Business and Oncology Drugs Information
15.1.3 SWOT Analysis of Roche
215.1.4 Roche Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.2 Merck & Co. Inc.
15.2.1 Company Profile
15.2.2 Main Business and Oncology Drugs Information
15.2.3 SWOT Analysis of Merck & Co. Inc.
215.2.4 Merck & Co. Inc. Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.3 Johnson & Johnson
15.3.1 Company Profile
15.3.2 Main Business and Oncology Drugs Information
15.3.3 SWOT Analysis of Johnson & Johnson
215.3.4 Johnson & Johnson Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.4 Bristol Myers Squibb
15.4.1 Company Profile
15.4.2 Main Business and Oncology Drugs Information
15.4.3 SWOT Analysis of Bristol Myers Squibb
215.4.4 Bristol Myers Squibb Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.5 Pfizer
15.5.1 Company Profile
15.5.2 Main Business and Oncology Drugs Information
15.5.3 SWOT Analysis of Pfizer
215.5.4 Pfizer Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.6 Novartis
15.6.1 Company Profile
15.6.2 Main Business and Oncology Drugs Information
15.6.3 SWOT Analysis of Novartis
215.6.4 Novartis Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.7 AbbVie
15.7.1 Company Profile
15.7.2 Main Business and Oncology Drugs Information
15.7.3 SWOT Analysis of AbbVie
215.7.4 AbbVie Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.8 Eli Lilly
15.8.1 Company Profile
15.8.2 Main Business and Oncology Drugs Information
15.8.3 SWOT Analysis of Eli Lilly
215.8.4 Eli Lilly Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.9 Amgen
15.9.1 Company Profile
15.9.2 Main Business and Oncology Drugs Information
15.9.3 SWOT Analysis of Amgen
215.9.4 Amgen Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.10 AstraZeneca
15.10.1 Company Profile
15.10.2 Main Business and Oncology Drugs Information
15.10.3 SWOT Analysis of AstraZeneca
215.10.4 AstraZeneca Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.11 Takeda
15.11.1 Company Profile
15.11.2 Main Business and Oncology Drugs Information
15.11.3 SWOT Analysis of Takeda
215.11.4 Takeda Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.12 GlaxoSmithKline
15.12.1 Company Profile
15.12.2 Main Business and Oncology Drugs Information
15.12.3 SWOT Analysis of GlaxoSmithKline
215.12.4 GlaxoSmithKline Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.13 Sanofi
15.13.1 Company Profile
15.13.2 Main Business and Oncology Drugs Information
15.13.3 SWOT Analysis of Sanofi
215.13.4 Sanofi Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.14 Merck KGaA
15.14.1 Company Profile
15.14.2 Main Business and Oncology Drugs Information
15.14.3 SWOT Analysis of Merck KGaA
215.14.4 Merck KGaA Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.15 Ipsen
15.15.1 Company Profile
15.15.2 Main Business and Oncology Drugs Information
15.15.3 SWOT Analysis of Ipsen
215.15.4 Ipsen Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.16 Bayer
15.16.1 Company Profile
15.16.2 Main Business and Oncology Drugs Information
15.16.3 SWOT Analysis of Bayer
215.16.4 Bayer Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.17 Regeneron Pharmaceuticals
15.17.1 Company Profile
15.17.2 Main Business and Oncology Drugs Information
15.17.3 SWOT Analysis of Regeneron Pharmaceuticals
215.17.4 Regeneron Pharmaceuticals Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.18 Gilead Sciences
15.18.1 Company Profile
15.18.2 Main Business and Oncology Drugs Information
15.18.3 SWOT Analysis of Gilead Sciences
215.18.4 Gilead Sciences Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.19 Hengrui Pharma
15.19.1 Company Profile
15.19.2 Main Business and Oncology Drugs Information
15.19.3 SWOT Analysis of Hengrui Pharma
215.19.4 Hengrui Pharma Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.20 Luye Pharma
15.20.1 Company Profile
15.20.2 Main Business and Oncology Drugs Information
15.20.3 SWOT Analysis of Luye Pharma
215.20.4 Luye Pharma Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Oncology Drugs Report
Table Data Sources of Oncology Drugs Report
Table Major Assumptions of Oncology Drugs Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Oncology Drugs Picture
Table Oncology Drugs Classification
Table Oncology Drugs Applications
Table Drivers of Oncology Drugs Market
Table Restraints of Oncology Drugs Market
Table Opportunities of Oncology Drugs Market
Table Threats of Oncology Drugs Market
Table COVID-19 Impact For Oncology Drugs Market
Table Raw Materials Suppliers
Table Different Production Methods of Oncology Drugs
Table Cost Structure Analysis of Oncology Drugs
Table Key End Users
Table Latest News of Oncology Drugs Market
Table Merger and Acquisition
Table Planned/Future Project of Oncology Drugs Market
Table Policy of Oncology Drugs Market
Table 2019-2029 North America Oncology Drugs Market Size
Figure 2019-2029 North America Oncology Drugs Market Size and CAGR
Table 2019-2029 North America Oncology Drugs Market Size by Application
Table 2019-2024 North America Oncology Drugs Key Players Revenue
Table 2019-2024 North America Oncology Drugs Key Players Market Share
Table 2019-2029 North America Oncology Drugs Market Size by Type
Table 2019-2029 United States Oncology Drugs Market Size
Table 2019-2029 Canada Oncology Drugs Market Size
Table 2019-2029 Mexico Oncology Drugs Market Size
Table 2019-2029 South America Oncology Drugs Market Size
Figure 2019-2029 South America Oncology Drugs Market Size and CAGR
Table 2019-2029 South America Oncology Drugs Market Size by Application
Table 2019-2024 South America Oncology Drugs Key Players Revenue
Table 2019-2024 South America Oncology Drugs Key Players Market Share
Table 2019-2029 South America Oncology Drugs Market Size by Type
Table 2019-2029 Brazil Oncology Drugs Market Size
Table 2019-2029 Argentina Oncology Drugs Market Size
Table 2019-2029 Chile Oncology Drugs Market Size
Table 2019-2029 Peru Oncology Drugs Market Size
Table 2019-2029 Asia & Pacific Oncology Drugs Market Size
Figure 2019-2029 Asia & Pacific Oncology Drugs Market Size and CAGR
Table 2019-2029 Asia & Pacific Oncology Drugs Market Size by Application
Table 2019-2024 Asia & Pacific Oncology Drugs Key Players Revenue
Table 2019-2024 Asia & Pacific Oncology Drugs Key Players Market Share
Table 2019-2029 Asia & Pacific Oncology Drugs Market Size by Type
Table 2019-2029 China Oncology Drugs Market Size
Table 2019-2029 India Oncology Drugs Market Size
Table 2019-2029 Japan Oncology Drugs Market Size
Table 2019-2029 South Korea Oncology Drugs Market Size
Table 2019-2029 Southeast Asia Oncology Drugs Market Size
Table 2019-2029 Australia Oncology Drugs Market Size
Table 2019-2029 Europe Oncology Drugs Market Size
Figure 2019-2029 Europe Oncology Drugs Market Size and CAGR
Table 2019-2029 Europe Oncology Drugs Market Size by Application
Table 2019-2024 Europe Oncology Drugs Key Players Revenue
Table 2019-2024 Europe Oncology Drugs Key Players Market Share
Table 2019-2029 Europe Oncology Drugs Market Size by Type
Table 2019-2029 Germany Oncology Drugs Market Size
Table 2019-2029 France Oncology Drugs Market Size
Table 2019-2029 United Kingdom Oncology Drugs Market Size
Table 2019-2029 Italy Oncology Drugs Market Size
Table 2019-2029 Spain Oncology Drugs Market Size
Table 2019-2029 Belgium Oncology Drugs Market Size
Table 2019-2029 Netherlands Oncology Drugs Market Size
Table 2019-2029 Austria Oncology Drugs Market Size
Table 2019-2029 Poland Oncology Drugs Market Size
Table 2019-2029 Russia Oncology Drugs Market Size
Table 2019-2029 MEA Oncology Drugs Market Size
Figure 2019-2029 MEA Oncology Drugs Market Size and CAGR
Table 2019-2029 MEA Oncology Drugs Market Size by Application
Table 2019-2024 MEA Oncology Drugs Key Players Revenue
Table 2019-2024 MEA Oncology Drugs Key Players Market Share
Table 2019-2029 MEA Oncology Drugs Market Size by Type
Table 2019-2029 Egypt Oncology Drugs Market Size
Table 2019-2029 Israel Oncology Drugs Market Size
Table 2019-2029 South Africa Oncology Drugs Market Size
Table 2019-2029 Gulf Cooperation Council Countries Oncology Drugs Market Size
Table 2019-2029 Turkey Oncology Drugs Market Size
Table 2019-2024 Global Oncology Drugs Market Size by Region
Table 2019-2024 Global Oncology Drugs Market Size Share by Region
Table 2019-2024 Global Oncology Drugs Market Size by Application
Table 2019-2024 Global Oncology Drugs Market Share by Application
Table 2019-2024 Global Oncology Drugs Key Vendors Revenue
Figure 2019-2024 Global Oncology Drugs Market Size and Growth Rate
Table 2019-2024 Global Oncology Drugs Key Vendors Market Share
Table 2019-2024 Global Oncology Drugs Market Size by Type
Table 2019-2024 Global Oncology Drugs Market Share by Type
Table 2024-2029 Global Oncology Drugs Market Size by Region
Table 2024-2029 Global Oncology Drugs Market Size Share by Region
Table 2024-2029 Global Oncology Drugs Market Size by Application
Table 2024-2029 Global Oncology Drugs Market Share by Application
Table 2024-2029 Global Oncology Drugs Key Vendors Revenue
Figure 2024-2029 Global Oncology Drugs Market Size and Growth Rate
Table 2024-2029 Global Oncology Drugs Key Vendors Market Share
Table 2024-2029 Global Oncology Drugs Market Size by Type
Table 2024-2029 Oncology Drugs Global Market Share by Type

Companies Mentioned

  • Roche
  • Merck & Co. Inc.
  • Johnson & Johnson
  • Bristol Myers Squibb
  • Pfizer
  • Novartis
  • AbbVie
  • Eli Lilly
  • Amgen
  • AstraZeneca
  • Takeda
  • GlaxoSmithKline
  • Sanofi
  • Merck KGaA
  • Ipsen
  • Bayer
  • Regeneron Pharmaceuticals
  • Gilead Sciences
  • Hengrui Pharma
  • Luye Pharma

Related Topics

Related Reports

Cancer Drugs Market - Global Forecast 2025-2032 - Product Image

Cancer Drugs Market - Global Forecast 2025-2032

  • Report
  • 183 Pages
  • Global
From
United States Cancer Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032 - Product Image

United States Cancer Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

  • Report
  • 80 Pages
  • United States
From
North America Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Country and Growth Forecast, 2023 - 2030 - Product Image

North America Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Country and Growth Forecast, 2023 - 2030

  • Report
  • 151 Pages
  • North America
From
Oncology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Oncology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Immuno-Oncology Drugs Market Report 2025 - Product Image

Immuno-Oncology Drugs Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.